Myasthenia Gravis Clinical Trials in Shanghai, Shanghai Municipality
8 recruitingShanghai, Shanghai Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Generalized Myasthenia Gravis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany264 enrolled138 locationsNCT06463587
Recruiting
Phase 3
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Generalized Myasthenia Gravis
Vor Biopharma180 enrolled105 locationsNCT06456580
Recruiting
Phase 1
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
Generalized Myasthenia Gravis
Candid Therapeutics44 enrolled1 locationNCT07215650
Recruiting
Phase 1
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Myasthenia GravisSystemic Lupus Erythematosus (SLE)Multiple Sclerosis (MS)+3 more
RenJi Hospital30 enrolled1 locationNCT06249438
Recruiting
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
Myasthenia Gravis
Huashan Hospital500 enrolled4 locationsNCT04535843
Recruiting
Phase 2
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Tang-Du Hospital64 enrolled6 locationsNCT05067348
Recruiting
Myasthenia Gravis Registry in China
Myasthenia Gravis
Huashan Hospital1,500 enrolled16 locationsNCT06241521
Recruiting
Study of Myasthenic Crisis in China
Myasthenia GravisMyasthenic Crisis
Huashan Hospital300 enrolled1 locationNCT04837625